1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Cardiovascular Devices Market Trends
  5. > Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Global Market Watch:
BRICSS Peripheral Vascular Devices sector forecasts to reach at US$732 million by 2016. China accounts for highest percentage approximately 34% (2015) and India follows next with nearly 25% (2018) of the market share.

BRICSS projections for Peripheral Vascular Stents market share indicate nearly 36% by 2015 leaving the rest of the market to the Vascular Closure Devices, AAA Stent Grafts, Inferior Vena Cava (IVC) Filters)…etc. Vascular Closure Devices market shows that the highest Compounded Annual Growth Rate (CAGR) of 14.7% during the analysis period 2012-2018.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

Report Focus:
The report ‘Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations.

The report primarily focuses on:
• Emerging Market Trends
• Advancements in the Technological Space
• Market Demand of The Segments (By-Region)
• Key Growth Areas and Market Size
• Region-Wise Demand Factor
• Key Competitors Edge
• Investment Strategies

The analysis primarily deals with by type. Further, the subdivided categories include:
Peripheral Vascular Devices – By Type
1. Peripheral Vascular Stents
a. Balloon-Expandable (BE)/Covered Stent
b. Self-Expanding (SE) Stents
2. Vascular Closure Devices
a. Active/Arterial Closure Devices
b. Passive Closure Devices
3. AAA Stent Grafts
4. Inferior Vena Cava (IVC) Filters
a. Retrievable Filters
b. Permanent IVC Filters
5. Peripheral Guidewires
6. Atherectomy Devices
a. Orbital
b. Rotational
c. Laser
d. Directional
7. Chronic Total Occlusion (CTO) Devices
8. Thrombectomy Devices
a. Percutaneous Aspiration Thrombectomy
b. Pullback Thrombectomy and Trapping
c. Recirculation Mechanical Thrombectomy
d. Direct Contact Mechanical Fragmentation &
e. Ultrasound
9. Embolic Protection Devices (EPD)
a. Carotid Artery Stenting
b. Transcatheter Aortic Valve Replacement (TAVR)
* EPD types include (filter devices, distal occlusion balloon devices & proximal 'or' catheter occlusion devices)

The period considered for the peripheral vascular devices market analysis is 2012-2018. The region wise distribution of the market consists of BRICSS (Brazil, Russia, India, China, South Korea and South Africa).

More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 133 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

Table Of Contents

Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018
I. REPORT FOCUS
A. INTRODUCTION

CARDIOLOGY

KINDS OF CARDIAC CONDITIONS
A. BLOOD FLOW IN THE HEART

B. HEART MALFUNCTION
TYPES OF CARDIAC ARREST

C. MYOCARDIUM
DISORDERS OF MYOCARDIUM

D. PERICARDIUM

E. HEART VALVES
DISORDERS OF HEART VALVES

F. CONGENITAL HEART DEFECT
TYPES OF CONGENITAL HEART DEFECT

G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES)

H. HEART FAILURE

B. CARDIOVASCULAR DEVICES
DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT
TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME
TOOLS DEPLOYED IN CARDIOLOGY
DIAGNOSTIC TESTS AND PROCEDURES
CONCLUSION

C. PERIPHERAL VASCULAR DEVICES
PERIPHERAL VASCULAR DISEASE (PVD)
AN EVALUATION OF BALLOON-EXPANDABLE-STENT IMPLANTATION WITH BALLOON ANGIOPLASTY IN PATIENTS WITH CORONARY ARTERY DISEASE
CARDIOVASCULAR DEATHS KEY FACTS

I. PERIPHERAL VASCULAR STENTS
APPROVED STENTS

II. VASCULAR CLOSURE DEVICES
MANUAL COMPRESSION

ARTERIAL CLOSURE DEVICES (ACDS):
PASSIVE VASCULAR CLOSURE DEVICES:
PASSIVE VASCULAR CLOSURE DEVICES - LIST OF DEVICES
ACTIVE VASCULAR CLOSURE DEVICES:
CONCLUSION

GLOBAL VASCULAR CLOSURE DEVICES MARKET WILL CONTRACT SCARCELY THROUGH 2022

III. AAA STENT GRAFTS
AAA PREVALENCE
AAA SYMPTOMS
AAA DIAGNOSIS
BENEFITS OF INTERVENTIONAL REPAIR
DISADVANTAGES OF INTERVENTIONAL REPAIR

IV. INFERIOR VENA CAVA (IVC) FILTERS
PREVALENT ISSUES RELATING TO FAILURE, TO INCLUDE DEATH (THE OTHER 4% OF CASES) INCLUDE

ANTICOAGULATION
SIDE EFFECTS

INFERIOR VENA CAVA FILTER PLACEMENT AND ABSTRACTION

RETRIEVAL

PERIPHERAL GUIDEWIRES

V. ATHERECTOMY DEVICES
THE UTILIZATION OF ATHERECTOMY AS EFFICACIOUS IN THE PERIPHERAL VESSELS IN PATIENTS WHO MEET THE FOLLOWING CRITERIA
COMPETITIVE CHANGES
MEDTRONIC LAUNCHES ASPIRATION CATHETER
STRATEGIES FOR OPTIMIZING ATHERECTOMY DEVICES SELECTION, TECHNIQUES
ATHERECTOMY: THE LITTLE DEVICES THAT COULD
COMPLEX DISEASE STATE

VI. CHRONIC TOTAL OCCLUSION (CTO) DEVICES
PERIPHERAL CTO CROSSING DEVICES
TRUPATH® PERIPHERAL CTO CROSSING DEVICES - FEATURES
VIANCE and ENTEER PERIPHERAL CTO CROSSING SOLUTIONS
CHRONIC TOTAL OCCLUSION ANGIOPLASTY IN THE UNITED STATES

BENEFITS OF CTO-PCI
THE BARRIERS TO PERFORMING CTO-PCI

CTO-PCI TECHNIQUES
1. ANTEGRADE TECHNIQUES
2. RETROGRADE TECHNIQUES

CONCLUSION

VII. THROMBECTOMY DEVICES
A. PERCUTANEOUS ASPIRATION THROMBECTOMY

B. PULLBACK THROMBECTOMY AND TRAPPING
MERCI RETRIEVAL SYSTEM

C. RECIRCULATION MECHANICAL THROMBECTOMY
HELIX CLOT BUSTER
THROMCAT THROMBECTOMY CATHETER
ANGIOJET
HYDROLYSER PERCUTANEOUS THROMBECTOMY CATHETER

D. DIRECT CONTACT MECHANICAL FRAGMENTATION

VIII. EMBOLIC PROTECTION DEVICES (EPD)
VARIOUS EPD TYPES ARE EXPOUNDED BELOW

A. BALLOON OCCLUSION DEVICES

B. CATHETER OCCLUSION DEVICES
ONE IN 4 CVADS MAY BECOME OCCLUDED
FIBRIN FORMATION IS A NATURAL PROCESS
SUMMARY

C. FILTER DEVICES

EPD PROCEDURES
A. CAROTID ARTERY STENTING
QUESTIONING THE SYSTEMS

B. TRANSCATHETER AORTIC VALVE (TAVR)
TAVR: A 10-YEAR EVOLUTION FROM CONCEPTION TO ESTABLISHED THERAPY
VALVE-IN-VALVE REGISTRY
TRANSCATHETER APPROACHES TO TREAT FAILING PROSTHETIC VALVES
ADVANCES IN IMAGING IN TAVR
ONGOING ISSUES IN TAVR
CONCLUSION

D. PERIPHERAL VASCULAR DEVICES - MARKET BRIEFING
CHINA
INDIA
BRAZIL
RUSSIA
SOUTH KOREA
SOUTH AFRICA

II. MARKET ANALYSIS
PERIPHERAL VASCULAR DEVICES - BRICSS - INDUSTRY SNAPSHOT

A. PERIPHERAL VASCULAR DEVICES - SEGMENTATION
PERIPHERAL VASCULAR DEVICES - GLOBAL
PERIPHERAL VASCULAR DEVICES - BRICSS

PERIPHERAL VASCULAR DEVICES - BY TYPE
PERIPHERAL VASCULAR DEVICES - BRICSS
PERIPHERAL VASCULAR STENTS
VASCULAR CLOSURE DEVICES (VCD)
AAA STENT GRAFTS
INFERIOR VENA CAVA (IVC) FILTERS
PERIPHERAL GUIDEWIRES
ATHERECTOMY DEVICES
CHRONIC TOTAL OCCLUSION (CTO) DEVICES
THROMBECTOMY DEVICES
EMBOLIC PROTECTION DEVICES (EPD)

B. GROWTH RATE ANALYSIS
BRICSS PERIPHERAL VASCULAR DEVICES - MARKET GROWTH RATES

PERIPHERAL VASCULAR DEVICES
BRICSS PERIPHERAL VASCULAR DEVICES - GROWTH RATES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW
FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
AN ENCOURAGING JAB FOR TORPID PERIODS

A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
CARDIAC RHYTHM MANAGEMENT DEVICES
CRM IN EUROPE

CARDIAC DEFIBRILLATORS
RAPID GROWTH IN DEFIBRILLATOR SALES

CARDIAC PACEMAKER DEVICES
THE DATA COLLECTION WORK

CARDIAC RESYNCHRONIZATION THERAPY (CRT)

CARDIAC MONITORING AND DIAGNOSTIC DEVICES
THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS
INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET
THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW

INTERVENTIONAL CARDIAC DEVICES
CORONARY STENTS
EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION

FFR IMPACT ON DES MARKET
MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET

CARDIAC CATHETERS
COMPETITIVE ANALYSIS

ELECTROPHYSIOLOGY CATHETERS (EP)
GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE
DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH

EP MAPPING
NEW AF ABLATION DEVICES SEEK APPROVAL

ATRIAL FIBRILLATION (AF)

INTRAVASCULAR ULTRASOUND (IVUS)
GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS

PERIPHERAL VASCULAR DEVICES
ARTERIOTOMY CLOSURE DEVICES
EMBOLIC PROTECTION DEVICES (EPD)
INFERIOR VENA CAVA (IVC) FILTERS
CONCLUSION

PERIPHERAL GUIDEWIRES
AV ACCESS THROMBECTOMY DEVICES

PROSTHETIC HEART VALVES
SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW
MARKET CHALLENGES

B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE
DRIVERS IN THE MEDICAL IMPLANT INDUSTRY
SIZE AND WEIGHT
POWER EFFICIENCY
PERFORMANCE SPECIFICATIONS
RISK MITIGATION AND RELIABILITY
EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES

C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE
CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY
IMPACT OF CVD IN EUROPE
IMPACT ON NEW YORK STATE
ECONOMIC IMPACT OF CVD IN NYS
HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION
IMPACT OF CVD ON ECONOMIC STABILITY

ECONOMIC COST OF CARDIOVASCULAR DISEASES

COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030

CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE

D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND

E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES

F. MARKET TRENDS
PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL
CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS
GE HEALTHCARE'S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS
GE'S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.
CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE
INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)
TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS
INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS
STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)
VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION
GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL
MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES
B. BRAUN'S INTROCAN SAFETY® 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD
MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING
RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH
A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN
ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY
SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE.
FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK'S NEW EVIA HF-T PACEMAKER.
AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL
SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS
USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS
MORTARA INSTRUMENT, INC. LAUNCHES “BUILT WITH PRIDE IN MILWAUKEE” CAMPAIGN.
MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT
DRUG-ELUTING STENTS ARE SECURE
CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE'S USER SATISFACTION SURVEY
ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME
ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT
ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE.
BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENTâ„¢ SOLUTIONS.
HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS
FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK
FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE “MOST ADMIRED COMPANY”
BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE
COOK MEDICAL TO INVEST €16.5M IN IRISH MEDICAL TECHNOLOGY MARKET
MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE
MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA.
NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY—INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH
FIRST IMPLANT OF BOSTON SCIENTIFIC'S WATCHMAN® DEVICE IN PATIENTS IN LATIN AMERICA
STUDY REVEALS THAT BAYER HEALTHCARE'S COTAVANCE® DRUG ELUTING BALLOONS WITH PACCOCATH® TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS.
USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS
SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011
TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY
CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL
SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC)
EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES.
ZOLL NOMINATED TO GLOBE 100 AGAIN
USCOM ENTERS EUROPEAN MARKETS
POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS
USCOM SECURES STRONG PRESENCE IN US AND CANADA
CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES
COVIDIEN INTRODUCES NEW GLOBAL PACKAGING
STENTYS'S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY.
SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT
CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD
USCOM EYES EASTERN EUROPEAN MARKET
VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART
INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES
INFECTIONS FROM IMPLANTED CARDIAC DEVICES
TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION
HEART TRANSPLANTS SUBSTITUTED BY A PUMP
DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF)
REMOTE MONITORING OF HEART FAILURE PATIENTS
EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES
OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION
IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH
OVER-THE-COUNTER APPARATUS
BOSTON SCIENTIFICS' IMPLANTABLE DEFIBRILLATOR
CARDIAC SCIENCE'S NEW CARDIAC TREATMENT
THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION
CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD
LOCAL MEDICARE'S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY
A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION
A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC
LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA
INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS
BEST AND LATEST SELF-TEACHING HEART SOUNDS
REPLACING VALVE WITHOUT CARDIAC SUPPORT
U.S. FDA GRANTS THE NAVISTAR® THERMOCOOL CATHETER FOR RAPID HEART BEAT
AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES
NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA
MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS

G. KEY COMPANY PROFILES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD

OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES

CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS

CARDIAC MEDICAL DEVICES - PATENTS

KEY COMPANIES FINANCIAL OVERVIEW

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX
RESEARCH FOCUS
ABOUT AXIS RESEARCH MIND
DISCLAIMER
FEEDBACK

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
European Market Report for Dialysis Catheters 2017 - MedCore

European Market Report for Dialysis Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European market for dialysis catheters comprises the acute hemodialysis, chronic hemodialysis and peritoneal dialysis catheter segments. The chronic hemodialysis catheter market is segmented ...

Denmark Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

Denmark Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

  • $ 5995
  • Industry report
  • September 2016
  • by Global Data

Denmark Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others Summary ...

Greece Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

Greece Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others

  • $ 5995
  • Industry report
  • September 2016
  • by Global Data

Greece Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others Summary GlobalData’s ...


Download Unlimited Documents from Trusted Public Sources

Cardiovascular Devices Industry in the US

  • September 2016
    8 pages
  • Cardiovascular ...  

  • United States  

View report >

Cardiovascular Devices Industry in Europe

  • May 2016
    9 pages
  • Cardiovascular ...  

  • Europe  

    Switzerland  

View report >

Therapy Market and Heart Attack Statistics - Forecast

  • May 2016
    9 pages
  • Therapy  

    Heart Attack  

    Cardiovascular ...  

View report >

Therapy Market In The Us

11 months ago

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.